ImmunityBio, Inc., a commercial-stage immunotherapy company based in the US, has announced a partnership with Biopharma ...
The Ministry of Health and Welfare (MoHW), South Korea government, and the Korea Health Industry Development Institute (...
US-based BostonGene, the developer of the leading AI foundation model for tumour and immune biology, has announced ...
Clinigen, a global leader in accelerating patient access to critical medicines, obtained the world's first prescription ...
Japan-headquartered Nxera Pharma has entered into a license agreement with a newly established independent company (NewC...
Singapore-based iX Biopharma has been awarded a $40.95 million development contract by the United States Government to f...
Galderma has announced the launch of Restylane Defyne and Restylane Refyne: the first Optimal Balance Technology (OBT)...
India's OneSource Specialty Pharma has received Saudi Food and Drug Authority (SFDA) approval of its generic Oze...
Iambic, a US-based clinical-stage life science and technology company developing novel medicines using its artificial in...
Singapore-headquartered Zuellig Pharma has acquired all rights, title, and interest in and to the Zam-Buk® and Vapex...
Budapest-based Gedeon Richter Plc. and Japan's Fuji Pharma Co. have announced the expansion and further strengthening of...
Kyowa Kirin, a Japan-based global specialty pharmaceutical company, has announced the termination of the current rocatin...
DHL Group has announced the expansion of its life sciences arm—DHL Health Logistics—with the development of ...
AstraZeneca strengthens its weight management portfolio through a new strategic collaboration agreement with China-based...
The Asian biopharma landscape is evolving rapidly and undergoing major shifts, expanding focus beyond generics and contr...
Why does TAXIS choose to focus on antimicrobial resistance? What are the key developments taking place at TAXIS to comba...
Life sciences M&A accelerated in 2025, with deal sizes increasing and total spend surpassing 2024 levels before the ...
Vetter, one of the world's leading pharmaceutical service providers for the production of injectable drugs, has confirme...
AstraZeneca has announced $15 billion investment in China through 2030 to expand medicines manufacturing and R&D. Th...
Japan-based H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio have announced the availability of the Lu...
Hanmi is accelerating its global market entry with efpeglenatide, Korea's first domestically developed GLP-1 c...
China-based Simcere Pharmaceutical Group and Germany-headquartered Boehringer Ingelheim have announced a license and col...
Palo Alto‑based PGxAI, a leader in AI-powered pharmacogenomics, and Saudi Arabia’s Novo Genomics ...
MS Pharma Group, a leading regional pharmaceutical company in the Middle East and North Africa (MENA) region, has signed...
Japan-based pharmaceutical firm Daiichi Sankyo has further established its presence in Canada with the official opening ...
GSK plc and Shionogi & Co. have reached an agreement together with Pfizer Inc. for the 11.7% economic interest in UK...
South Korea based Alteogen Inc. has entered into an exclusive license agreement with Tesaro, Inc., a subsidiary of GSK. ...
D. Western Therapeutics Institute, Inc. (DWTI) has announced that Kowa Co., Ltd., to which DWTI out-licensed its in-hous...
US-based Pacira BioSciences, Inc. has entered into an agreement with South Korea's LG Chem designed to expand access to ...
US-based Rakuten Medical, Inc. and South Korea's Lotte Biologics have signed a biopharmaceutical contract manufacturing ...
Novartis, a leading global innovative medicines company, has announced plans to build its fourth US radioligand therapy ...
US-based Nuvation Bio Inc., a global oncology company focused on tackling some of the toughest challenges in cancer trea...
Taiwan based OBI Pharma has entered into a commercial license agreement with TegMine Therapeutics, Inc., a San Francisco...
Japanese pharmaceutical firm Takeda has announced a global collaboration and license agreement with US-based Halozyme Th...
US-based Revvity, Inc. has announced a collaboration with Eli Lilly and Company (Lilly) that expands acce...
Swiss firm Santhera Pharmaceuticals has signed an exclusive licensing agreement with Nxera Pharma UK for the development...
Taiwan-based Foresee Pharmaceuticals has announced that Foresee Pharmaceuticals USA Inc., the company's fully-owned US s...
Ribo Life Science Co., a leading company in small interfering RNA (siRNA) therapeutics, has successfully listed on the M...
Japan's Kyorin Pharmaceutical has entered into an exclusive distribution agreement with Lunatus Marketing & Consulti...
Sanofi K.K. and Taiho Pharmaceutical have announced that the sales of the anticancer agent Jevtana® I.V. Infusion 60...
Singapore-based Hyphens Pharma International has granted the rights to commercialise its innovative product, Cerapro®...
ScinoPharm Taiwan has announced a landmark achievement in the global pharmaceutical landscape, securing US Food and Drug...
Japan's Shionogi & Co. will acquire a newly established company that Tanabe Pharma Corporation will create to hold t...
China-based Mabwell, an innovation-driven biopharmaceutical company with a fully integrated industry chain, has announce...
Asia-Pacific’s life sciences landscape has always been shaped by contrasts. It is a region where scale and sophist...
The COVID-19 pandemic acted as both a challenge and a catalyst, serving as a testbed that fundamentally reshaped the bio...
mRNA first entered the global spotlight during COVID-19, turning companies such as Moderna and BioNTech into household n...
Indian pharma major Lupin Limited has entered into an exclusive License, Supply and Distribution agreement with Gan &...
French biopharmaceutical firm Sanofi has entered into an agreement to acquire US-based Dynavax Technologies Corporation,...
Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences and...
Novo Nordisk has announced that the US Food and Drug Administration (FDA) has approved once-daily Wegovy® pill,...
Asahi Kasei Pharma Corporation has announced plans to relocate its R&D hub from Izunokuni City, Shizuoka Prefecture ...
China-based Jacobio Pharma has entered an agreement with AstraZeneca for its proprietary Pan-KRAS inhibitor JAB-23E73.&n...
South Korea-based Lunit, a leading provider of AI for cancer diagnostics and precision oncology, has announced a collabo...
The healthcare industry in Asia Pacific (APAC), home to half the world's population, faces a dual reality: immense oppor...
Kyowa Kirin, a Japan-based global specialty pharmaceutical company, has announced the Board of Directors’ decision...
Japan-based Chugai Pharmaceutical has announced the establishment of a new partnering office in South San Francisco, US....
Eli Lilly and Company has announced a plan to invest more than $6 billion in a new manufacturing facility in Huntsville,...
Singapore-based Zuellig Pharma, a leading healthcare solutions company in Asia, has expanded its partnership with H...
China's Fosun Pharma announced that its subsidiaries, Chongqing Yao Pharmaceutical Company, Shanghai Fosun Pharmaceutica...
Vietnam’s burgeoning tech ecosystem is poised to ignite a vibrant new era of cross-continental collaboration and i...
At the 2nd International Forum of Pharmaceutical Inspectorates (IFPI), held on November 24–25 at the Marriott Hote...
Pillar Biosciences and AstraZeneca have announced an expansion of their existing laboratory access programme for NG...
ChemLex, a next-generation AI-for-science company, today announced the establishment of its global headquart...
Australia-based Immutep Limited and Dr. Reddy’s Laboratories, based in India, have announced that their ...
Japan's Santen Pharmaceutical and the Singapore Eye Research Institute (SERI) have launched the Santen–SERI Open I...
South Korea-based Samsung Bioepis Co. has announced the launch of OBODENCE™ (60 mg pre-filled syringe) a...
Japan's Fujitsu Limited has announced the development of a multi-AI agent collaboration technology that enable...
SAI Parenterals Limited (SPL), an India-based pharmaceutical formulation company, has announced the acquisition of a 74....
Beyond tariff cuts, FTAs deliver deep structural benefits through regulatory alignment and facilitation of trade. Firms ...
In both the US and Japan, regulators provide an extensive set of resources detailing the rules and specifications govern...
In today’s global, multi-provider clinical trial environment, sponsors need to rapidly and accurately assess vast ...
In 2026, oncology drug development in Asia may move away from the historical maximum tolerated dose (MTD) paradigm towar...
2025 was the year when China’s stratospheric rise on the global biotech stage continued. According to a report fro...
The US Food and Drug Administration (FDA) has approved Itvisma (onasemnogene abeparvovec-brve) for the treatment of spin...
Hikma Pharmaceuticals PLC, the multinational pharmaceutical company, has signed an exclusive licensing agreement wi...
Jyong Biotech, a science-driven biotechnology company based in Taiwan committed to developing and commercialising innova...
Singapore headquartered Prestige Biopharma, a biopharmaceutical company specialising in antibody therapeutics, has annou...
Algorithm, a pioneering regional pharmaceutical manufacturer has announced the signing of a strategic partnership agreem...
When Najat Khan steps into her new role as CEO and President of Recursion, she inherits more than a celebrated...
The 93rd API China, held from November 12 to 14, 2025, at the Chongqing International Expo ...
The 93rd API China, China’s first and longest-running pharmaceutical ingredients exhibition, took place from 12&nd...
Australia's Telix Pharmaceuticals has announced the official opening of Telix Manufacturing Solutions (TMS) in Yoko...
Japan-headquartered Nxera Pharma has announced a focused restructuring designed to concentrate investment and resources ...
Global biopharma leader CSL has announced plans to expand its US presence over the next five years, resulting in approxi...
As a key step in Bayer’s “In China, for Global” strategy, the Bayer E-Town Open Innovation Center offi...
South Korea-based ABL Bio, a company specializing in bispecific antibodies, has entered license, research and collaborat...
Anand Shetty, Corporate Vice President, Southeast Asia, Novo Nordisk (left) Dr Abel Soh, Consultant Endocrinologist f...
Puerto Rico’s transformation into a powerhouse of advanced biopharmaceutical manufacturing is gaining new momentum...
Japan's Meiji Seika Pharma has decided to establish a local subsidiary in Singapore to strengthen its presence and exp...
Taiwan-based EirGenix Inc. has entered into a second global exclusive licensing agreement with international biosimilar ...
Kaigene Inc., a US-based biotechnology startup pioneering next-generation antibody therapeutics for autoimmune disorders...
Boehringer Ingelheim, one of the world’s leading research-driven pharmaceutical companies, has announced that the&...
In a special conversation with BioSpectrum Asia, Yang Huang, Head of China Healthcare Research at J.P. Morgan, shares sh...
Clariant, a global specialty chemicals leader, has announced the completion of its state-of-the-art facility expansion a...
The SingHealth Duke-NUS Academic Medical Centre today announced the establishment of two new centres — the C...
Novo Nordisk has announced the launch of Wegovy® in Hong Kong, now available at private clinics and selected pharmac...
TechInnovation 2025 concluded on an inspiring note as leaders from long-standing industries shared how they are transfor...
Vietnam’s pharmaceutical market is expanding rapidly. According to Fitch Solutions, it was valued at $6 billion in...
TechInnovation 2025, organised by IPI Singapore, continued to Day 2 at Sands Expo & Convention Centre, Level 3,...
